Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究
基本信息
- 批准号:10662839
- 负责人:
- 金额:$ 99.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAfrican American populationAlcoholsAnimal ExperimentsAnimalsAreaBehavioralBiological MarkersBiological Specimen BanksBiological Specimen databaseCOVID-19 testingCause of DeathCessation of lifeCirrhosisClinicalCocaineCocaine AbuseCocaine UsersDataDatabasesDiagnostic EquipmentDiseaseDisease OutcomeDrug abuseEtiologyFDA approvedFloridaFundingFutureGenetic MarkersGoalsHIVHIV InfectionsHIV/HCVHealthHealth Services AccessibilityHepatitis CHepatitis C TherapyHepatitis C co-infectionHepatitis C virusHeterosexualsHispanicHispanic PopulationsHumanImmunityImmunosuppressionIn VitroInterventionLaboratoriesLiver FibrosisLiver diseasesMagnetic Resonance ElastographyMalnutritionMetabolicMorbidity - disease rateNatureOutcomeOxidative StressParticipantPathogenesisPatternPersonsPharmaceutical PreparationsPharmacotherapyPopulationPopulations at RiskPrimary carcinoma of the liver cellsPrognostic FactorProgram DevelopmentProgram EvaluationQuality of lifeRecording of previous eventsResearchResearch DesignResourcesRisk FactorsRoleSignal TransductionStimulusSubstance abuse problemTreatment FailureUnderserved PopulationUnited StatesUnited States National Institutes of HealthVirus DiseasesVulnerable PopulationsWomanantifibrotic treatmentantiretroviral therapychronic liver diseaseco-infectioncocaine usecohortcommunity engaged researchcomorbiditycytokinedata harmonizationdrug of abuseeffective interventioneffective therapyevidence basefibrogenesisfollow-uphealth care availabilityhealth disparityhealth disparity populationsimprovedinsightinterestliver developmentmortalitynoninvasive diagnosisnovelpreventprogramsprospectiverecruitretention ratesociodemographicstime intervaltransmission processtreatment effectuptake
项目摘要
ABSTRACT
Liver disease is a major cause of death in HIV infected persons in the United States. While advances in
antiretroviral therapy have significantly reduced HIV-related mortality, co-infection with hepatitis C virus
(HCV), is widespread and accelerates progression of liver fibrosis to cirrhosis and liver carcinoma. In
addition, substance abuse accelerates HIV disease, and may facilitate progression of liver fibrosis. The
primary goal of this proposal is to continue to follow the existing Miami Adult Studies on HIV (MASH) cohort,
its specimen repository and database, and expand it from the current 881 to 1,500 study participants. The
purpose is to generate collaborative studies to investigate the impact of cocaine, by far the most prevalent
drug of abuse in South Florida, on HIV infection, HIV/HCV co-infection, and on long-term morbidity with a
focus on liver disease in this population with disparities in access to care. HIV and HCV un-infected cocaine
users and non-users will also be recruited to allow determination of the impact of cocaine use alone, as well
as the interaction of cocaine use with HIV, HCV, and HIV/HCV co-infection. As new and more effective
treatments and access to care for HIV, HCV and drug abuse become available, maintaining a well-
characterized cohort, specimen repository and database will create a strong resource platform for current
and future collaborative research. Observing the uptake of new HCV treatments and potential new cocaine
cessation programs in this at-risk population with health disparities will provide data on barriers and facilitators
to effective treatments to prevent long-term morbidity and mortality. We have followed the MASH cohort of 881
participants for up to 12 years with excellent retention rates, and have created a specimen repository and a
database. The MASH cohort in Miami is unique because it will be a mostly Hispanic cohort with a large
number of African Americans, women, non-injector drug users, with predominantly heterosexual HIV-
transmission etiology. We propose to (1) compare the progression of liver fibrosis over four years among
cocaine users and non-users in HIV+/HCV-, HIV+/HCV+, HIV-/HCV+, and HIV-/HCV-, using a novel non-
invasive diagnostic device, the Magnetic Resonance Elastography (MRE). We also propose to (2) compare
the pattern over four years of biomarkers and identify genetic markers associated with the mechanisms of liver
fibrosis among cocaine users and non-users. Understanding the role of cocaine use in the context of HIV and
HIV/HCV co-infections and lack of lasting effects of treatments for cocaine use cessation are crucial in order to
gain insights into the pathogenesis and disease outcomes, and to provide the basis for identifying antifibrotic
therapies such as oxidative stress, which are amenable to intervention. These studies will be critical for
program development, appropriate interventions, and for improving health in this population.
抽象的
肝病是美国艾滋病毒感染者死亡的主要原因。虽然在进步
抗逆转录病毒治疗显着降低了艾滋病毒相关死亡率和丙型肝炎病毒合并感染
(HCV),广泛存在并加速肝纤维化进展为肝硬化和肝癌。在
此外,药物滥用会加速艾滋病毒的发病,并可能促进肝纤维化的进展。这
该提案的主要目标是继续跟踪现有的迈阿密成人艾滋病毒研究 (MASH) 队列,
其样本库和数据库,并将其从目前的 881 名研究参与者扩大到 1,500 名研究参与者。这
目的是开展合作研究来调查可卡因的影响,可卡因是迄今为止最流行的
南佛罗里达州滥用药物、艾滋病毒感染、艾滋病毒/丙型肝炎病毒合并感染以及长期发病率
重点关注这一人群中的肝病,但获得护理的机会存在差异。未感染 HIV 和 HCV 的可卡因
还将招募使用者和非使用者来确定可卡因单独使用的影响
可卡因使用与 HIV、HCV 以及 HIV/HCV 合并感染之间的相互作用。作为新的和更有效的
艾滋病毒、丙型肝炎病毒和药物滥用的治疗和护理变得可用,从而维持良好的
特征队列、标本库和数据库将为当前的研究创建一个强大的资源平台。
以及未来的合作研究。观察新的丙肝病毒治疗方法和潜在的新可卡因的使用情况
针对存在健康差异的高危人群的戒烟计划将提供有关障碍和促进因素的数据
采取有效的治疗方法来预防长期发病和死亡。我们追踪了 MASH 队列中的 881 人
参与者长达 12 年,具有出色的保留率,并创建了样本库和
数据库。迈阿密的 MASH 队列是独一无二的,因为它将主要是西班牙裔队列,并且有大量
非裔美国人、妇女、非注射吸毒者(主要是异性恋艾滋病毒使用者)的数量
传播病因学。我们建议(1)比较四年来肝纤维化的进展情况
HIV+/HCV-、HIV+/HCV+、HIV-/HCV+ 和 HIV-/HCV- 的可卡因使用者和非使用者,使用一种新型非
侵入性诊断设备,磁共振弹性成像(MRE)。我们还建议(2)比较
四年的生物标志物模式并识别与肝脏机制相关的遗传标志物
可卡因使用者和非使用者之间的纤维化。了解可卡因使用在艾滋病毒和艾滋病毒背景下的作用
HIV/HCV 双重感染以及可卡因戒断治疗缺乏持久效果至关重要
深入了解发病机制和疾病结果,并为识别抗纤维化提供基础
诸如氧化应激之类的疗法,可以进行干预。这些研究对于
计划的制定、适当的干预措施以及改善该人群的健康。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bidirectional associations between e-cigarette use and alcohol use across adolescence.
- DOI:10.1016/j.drugalcdep.2020.108496
- 发表时间:2021-03-01
- 期刊:
- 影响因子:4.2
- 作者:Lozano A;Liu F;Lee TK;Prado G;Schwartz SJ;Leventhal AM;Kelleghan AR;Unger JB;Barrington-Trimis JL
- 通讯作者:Barrington-Trimis JL
Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort.
- DOI:10.1371/journal.pone.0275675
- 发表时间:2022
- 期刊:
- 影响因子:3.7
- 作者:Hernandez, Jacqueline;Tamargo, Javier A.;Martinez, Sabrina Sales;Martin, Haley R.;Campa, Adriana;Sekaly, Rafick-Pierre;Bordi, Rebeka;Sherman, Kenneth E.;Rouster, Susan D.;Meeds, Heidi L.;Khalsa, Jag H.;Mandler, Raul N.;Lai, Shenghan;Baum, Marianna K.
- 通讯作者:Baum, Marianna K.
Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort.
- DOI:10.1080/09540121.2021.1896660
- 发表时间:2022-05
- 期刊:
- 影响因子:1.7
- 作者:Degarege A;Krupp K;Tamargo J;Martinez SS;Campa A;Baum M
- 通讯作者:Baum M
Effectiveness of a 6-Month Nutrition Intervention in People Living with HIV and Prediabetes Progressing through Stages of Change towards Positive Health Behavior.
- DOI:10.3390/ijerph192214675
- 发表时间:2022-11-08
- 期刊:
- 影响因子:0
- 作者:Sneij, Alicia;Campa, Adriana;Huffman, Fatma;George, Florence;Trepka, Mary Jo;Martinez, Sabrina Sales;Baum, Marianna
- 通讯作者:Baum, Marianna
PNPLA3 Single Nucleotide Polymorphism Prevalence and Association with Liver Disease in a Diverse Cohort of Persons Living with HIV.
- DOI:10.3390/biology10030242
- 发表时间:2021-03-21
- 期刊:
- 影响因子:4.2
- 作者:Sherman KE;Rouster SD;Meeds H;Tamargo J;Chen J;Ehman R;Baum M
- 通讯作者:Baum M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marianna K Baum其他文献
Marianna K Baum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marianna K Baum', 18)}}的其他基金
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
- 批准号:
10544758 - 财政年份:2022
- 资助金额:
$ 99.13万 - 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
- 批准号:
10447463 - 财政年份:2022
- 资助金额:
$ 99.13万 - 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
- 批准号:
9927614 - 财政年份:2015
- 资助金额:
$ 99.13万 - 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
- 批准号:
9144756 - 财政年份:2015
- 资助金额:
$ 99.13万 - 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
- 批准号:
9494556 - 财政年份:2015
- 资助金额:
$ 99.13万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
7590839 - 财政年份:2008
- 资助金额:
$ 99.13万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
8080463 - 财政年份:2008
- 资助金额:
$ 99.13万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
8278027 - 财政年份:2008
- 资助金额:
$ 99.13万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
7857921 - 财政年份:2008
- 资助金额:
$ 99.13万 - 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
- 批准号:
7691806 - 财政年份:2008
- 资助金额:
$ 99.13万 - 项目类别:
相似海外基金
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
- 批准号:
10577022 - 财政年份:2023
- 资助金额:
$ 99.13万 - 项目类别:
Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up
中年痴呆症风险因素的早期预测因素:35 年随访
- 批准号:
10596295 - 财政年份:2023
- 资助金额:
$ 99.13万 - 项目类别:
A Mobile-Delivered Personalized Feedback Intervention for Black Individuals who Engage in Hazardous Drinking
针对有害饮酒的黑人的移动提供的个性化反馈干预
- 批准号:
10821512 - 财政年份:2023
- 资助金额:
$ 99.13万 - 项目类别:
Gene-Environment Interplay and Alcohol Use among Racially-Ethnically Diverse Youth: A Developmentally and Culturally Informed Approach
种族-民族多元化青年中的基因-环境相互作用和酒精使用:一种发展和文化知情的方法
- 批准号:
10779197 - 财政年份:2023
- 资助金额:
$ 99.13万 - 项目类别:
Effects of Direct and Vicarious Discrimination on Alcohol and Cannabis Cravings: Virtual Reality Experiment
直接和间接歧视对酒精和大麻渴望的影响:虚拟现实实验
- 批准号:
10712560 - 财政年份:2023
- 资助金额:
$ 99.13万 - 项目类别: